SCHEMBL20719871

SCHEMBL20719871

CN1CCc2ncc(N)cc2C(=O)C1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.36
RAF1 P04049 1/20 0.36
CYP2C9 P11712 2/20 0.33
KDR P35968 1/20 0.33
CYP2D6 P10635 1/20 0.33
F12 P00748 3/20 0.32
BMPR1A P36894 3/20 0.32
ACVRL1 P37023 3/20 0.32
ACVR1 Q04771 3/20 0.32
GRM5 P41594 1/20 0.31
ATR Q13535 1/20 0.31
CYP1A2 P05177 2/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31553839 0.78 RAF1 (0.40) RAF1ACVRL1ACVR1GRM5MEN1
SCHEMBL29520297 0.78 CYP2C19 (0.44) CYP2C19CYP2C9CYP1A2ALDH1A1KDM4E
SCHEMBL3440728 0.78 CYP2C19 (0.44) CYP2C19CYP2C9CYP1A2ALDH1A1KDM4E
SCHEMBL3440773 0.74 MAOA (0.40) CYP2C19
SCHEMBL31553854 0.69 CYP11B2 (0.34) RAF1GRM5ALDH1A1KDM4EMEN1
SCHEMBL8030862 0.67 GRM5 (0.56) GRM5ALDH1A1KDM4EKMT2A
SCHEMBL31553816 0.65 NR1H2 (0.39) MAPT
SCHEMBL5863676 0.65 CDC7 (0.40) KDM4E
Hydrochloric Acid SCHEMBL11067822 0.65 CYP2C19 (0.44) CYP2C19CYP2C9GRM5CYP1A2ALDH1A1
SCHEMBL31553851 0.65 CDC7 (0.40) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10590128-B2 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands PFIZER, INC. (US) 2020-03-17 US disclosed
US-20190047997-A1 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS PFIZER INC. (US) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10590128-B2 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands DRD3, DRD2, DRD4 CYP2C19 122/4885RAF1 2443/4885CYP2C9 346/4885
US-20190047997-A1 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS DRD3, DRD2, DRD4 CYP2C19 122/4885RAF1 2443/4885CYP2C9 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.